---
title: "Sundrug to Grant Restricted Treasury Shares as Equity Compensation to Executives"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291024254.md"
description: "Sundrug Co (JP:9989) approved granting 15,300 restricted treasury shares as equity compensation to eight executives, valued at approximately ¥58.2 million. This action aligns with a previously approved plan to tie management compensation to corporate value and shareholder interests through long-term transfer restrictions. The move aims to strengthen governance, retention, and strategic focus."
datetime: "2026-06-27T05:22:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291024254.md)
  - [en](https://longbridge.com/en/news/291024254.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291024254.md)
---

# Sundrug to Grant Restricted Treasury Shares as Equity Compensation to Executives

Sundrug Co ( (JP:9989) ) has provided an announcement.

Sundrug has approved the disposal of 15,300 treasury shares as restricted stock compensation for eight internal directors and executive officers, with a disposal value of about ¥58.2 million at ¥3,807 per share. The move forms part of a previously approved restricted stock plan designed to tie management and key personnel compensation more closely to corporate value and shareholder interests, using long-term transfer restrictions and potential clawbacks to align incentives.

Under the plan, eligible directors and officers will contribute their monetary claims in kind to receive common shares subject to transfer restrictions until retirement or resignation from designated roles at Sundrug or its subsidiaries. By deepening equity-based pay and linking tenure and performance to stock allocation, Sundrug strengthens governance and retention of key leaders, potentially enhancing long-term strategic focus and aligning management behavior with shareholder value creation.

The most recent analyst rating on (JP:9989) stock is a Hold  
with a Yen4400.00 price target.  
To see the full list of analyst forecasts on Sundrug Co stock,  
see the JP:9989 Stock Forecast page.

**More about Sundrug Co**

Sundrug Co., Ltd. is a Japan-based drugstore operator listed on the Tokyo Stock Exchange Prime Market, focusing on retail sales of pharmaceuticals, cosmetics, daily necessities, and related health products. The company targets consumers across Japan through a chain-store model, positioning itself as a comprehensive healthcare and lifestyle retailer in a competitive domestic drugstore market.

**Average Trading Volume:** 499,488

**Technical Sentiment Signal:** Hold

**Current Market Cap:** Yen443.4B

Find detailed analytics on 9989 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [9989.JP](https://longbridge.com/en/quote/9989.JP.md)

## Related News & Research

- [Sundrug (TSE:9989) Stock Holds Ground As Margins Tighten](https://longbridge.com/en/news/296035453.md)
- [Medicure says six-month revenue growth is driven by rising Zypitamag sales via Marley Drug and insured customers](https://longbridge.com/en/news/296398933.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)
- [Is Sunoco (SUN) Turning Value Credentials Into a Stronger Motor Fuels Investment Story?](https://longbridge.com/en/news/296393733.md)
- [Meeder Asset Management Inc. Makes New $1.36 Million Investment in Sun Communities, Inc. $SUI](https://longbridge.com/en/news/296337000.md)